Clinical Trial Update: Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating interferon alfa with or without vaccine therapy in patients with metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Melanoma (Skin) | Phase 3 | Status: UNKNOWN